Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News VivoSim Labs Inc VIVS

Healthcare Biotechnology
VivoSim Labs, Inc., formerly Organovo Holdings, Inc., is a clinical-stage biotechnology company. The Company is developing drugs that are demonstrated to be effective in three-dimensional (3D) human tissues as candidates for drug development. It focuses on developing novel treatment approaches in inflammatory bowel disease (IBD). Its proprietary technology is used to build 3D human tissues that... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:VIVS)

VivoSim's NAMKind(TM) Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference

GlobeNewswire 2 days ago

VivoSim Presents Best-in-Class Liver Toxicology Prediction Results at Digestive Disease Week Conference

GlobeNewswire 8 days ago

VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market

GlobeNewswire April 24, 2025

VivoSim to Carry Forward Organovo 3D Bioprinting

GlobeNewswire April 23, 2025

Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements

GlobeNewswire April 2, 2025

Organovo Provides Business Update

GlobeNewswire March 27, 2025

Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company

GlobeNewswire March 25, 2025

Organovo Announces Reverse Stock Split

GlobeNewswire March 19, 2025

Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors

GlobeNewswire March 11, 2025
View More News ››

Opinion & Analysis (NDAQ:VIVS)

3D printing is a manufacturing game-changer

Richard (Rick) Mills November 15, 2019

Cutting-edge devices and diagnostics deliver drugs and profits: Cantor Fitzgerald's Caroline Corner

George S. Mack July 31, 2015

The Calandra Report: More biotech, Bitterroot, CTIX, BCRX, CUR and more

Thom Calandra January 14, 2014
View More Opinion ››

Bullboard Posts (NDAQ:VIVS)

Organovo Holdings, Inc. (ONVO): Advancing Clinical Developme

http://beyondspx.com/2024/08/01/organovo-holdings-inc-onvo-advancing-clinical-development-of-fxr314-and-building-high-fidelity-3d-tissue...
MikeTester - August 2, 2024

ONVO....The Perfect Storm?

Go ahead ....I dare ya ; ) A positive News Released this a.m with an S-1 filed and Effective EDGAR Entity Landing Page (sec.gov)
Iseneschal - April 15, 2024

adding more shares here today

using dollar cost averaging for this one,so glta.
coolfooldumbguy - May 31, 2019

it's a buy today for me

at the 75 cent mark,so glta.
coolfooldumbguy - May 30, 2019

RE:and then they were 2

my god. since 2015... hope you've cash in many times... have you looked at its charts?  It might take another long run before...
alphatradr - June 6, 2018

RE:ONVO RSP Long term hold

remains a long shot but what a long shot it is .....good luck Dmaster
dmastercard - January 29, 2018
View more Bullboard ››

Lahontan Gold Corp.

Lahontan Gold Corp.

Lahontan Gold Corp. is a Canadian mine development and mineral exploration company. The Company is engaged in the ...
View More »